MRK's $10B buyout of VRNA brings in Ohtuvayre, a unique COPD therapy set to bolster its cardio-pulmonary portfolio.

Fintel reports that on July 10, 2025, Wells Fargo downgraded their outlook for Verona Pharma plc - Depositary Receipt () ...

Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...

The main patent for Ohtuvayre, the COPD drug at the heart of Verona’s $10 billion sale, expired in 2020. For Merck to make ...

M ANKATO, Minn. (KEYC) - The Minnesota Pollution Control Agency has issued an air quality alert for all of Minnesota until 9 ...

Interstitial lung abnormalities (ILAs) are parenchymal lung changes found on high-resolution CT. In routine use of high-resolution CT, non-specific findings are frequently reported, which has prompted ...

The FDA has accepted for priority review a new supplemental biologics license application for Winrevair to treat adults with ...

Objectives The association between smoking and patients with schizophrenia has been established through epidemiological ...